Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May



  Illumina to Webcast Live Presentation at Upcoming Investment Conferences in
  May

Bank of America Merrill Lynch 2013 Healthcare Conference Robert W. Baird
Growth Stock Conference 2013 2013 UBS Global Healthcare Conference

Business Wire

SAN DIEGO -- May 1, 2013

Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the
Company’s presentation at three upcoming investment conferences.

Illumina will webcast its presentation at the Robert W. Baird Growth Stock
Conference in Chicago, Illinois, on May 8, 2013. The live webcast is scheduled
to begin at 2:10 PM CT and will feature a brief overview of the company by
Christian Henry, Senior Vice President and General Manager, Genomic Solutions,
followed by a question and answer session.

Illumina will also webcast its presentation at the Bank of America Merrill
Lynch Health Care Conference in Las Vegas, Nevada, on May 14, 2013. The live
webcast is scheduled to begin at 4:20 PM PT and will feature an overview of
the company by Jay Flatley, President and Chief Executive Officer, followed by
a question and answer session.

Illumina will also webcast its presentation at the UBS Global Healthcare
Conference in New York, New York, on May 20, 2013. The live webcast is
scheduled to begin at 11:30 AM ET and will feature a brief overview of the
company by Marc Stapley, Senior Vice President and Chief Financial Officer,
followed by a question and answer session.

The webcast can be accessed in the Investor Relations section of Illumina's
web site under the "Company" tab at www.illumina.com.

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer
of life science tools and integrated systems for the analysis of genetic
variation and function. We provide innovative sequencing and array-based
solutions for genotyping, copy number variation analysis, methylation studies,
gene expression profiling, and low-multiplex analysis of DNA, RNA, and
protein. We also provide tools and services that are fueling advances in
consumer genomics and diagnostics. Our technology and products accelerate
genetic analysis research and its application, paving the way for molecular
medicine and ultimately transforming healthcare.

Contact:

Illumina, Inc.
Investors:
Rebecca Chambers, 858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple, 858-882-6822
pr@illumina.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement